Zobrazeno 1 - 10
of 50
pro vyhledávání: '"RALPH G. ROBINSON"'
Autor:
Carol Balmer, Frans M.J. Debruyne, E. David Crawford, Christopher J. Logothetis, Arthur T. Porter, James M. Kozlowski, William R. Fair, Ralph G. Robinson, David Kirk
Publikováno v:
Urology. 44:481-485
From the Division of Urology, University of Colorado Health Sciences Center, Denver, Colorado; the Genitourinary Oncology Program and the Department of Urology, Northwestern University Medical School, Chicago, Illinois; the Department of Urology, Nij
Publikováno v:
Spine. 19:1956-1962
To gain a better understanding of factors affecting dorsal implant pull-out strength and stiffness so thoracic spinal implant fixation can be improved.Posterior pull-out testing of six thoracic implant anchor types was performed on 54 osteoporotic hu
Publikováno v:
Spine. 19:1664-1673
Study design Effects of spinal implant stiffness and removal/retention on bypassed bone mineral density and column/fusion stiffness were studied in dogs. Methods After facet fusion and bicortical peripedicle screw placement, one group of eight dogs r
Autor:
Ralph G. Robinson, David B. Wilson, Dewey K. Ziegler, Kirk G. Baxter, Karen A. Haffey, Stephanie L. Lawhorn, Daniel H. Jacobs
Publikováno v:
Journal of Stroke and Cerebrovascular Diseases. 4:81-85
Patients with symptomatic cerebrovascular disease suffer a high mortality from myocardial ischemia, which may occur during rest or following the conclusion of exercise. In a pilot study, we screened 11 patients with transient cerebral ischemic attack
Publikováno v:
Spine. 18:1862-1866
A canine spine surgery model was used to study bone mineral loss induced in vertebrae bypassed by stiff implants. Loosening of implants was measured, and a determination was made as to the effect of loosening on the degree of bone mineral loss. Sixte
Autor:
Ralph G. Robinson
Publikováno v:
Cancer. 72:3433-3435
Strontium-89 is a radioactive calcium analog that provides an energetic beta particle for radiation therapy of osteoblastic disease. Strontium-89 is used as palliative therapy with the primary goal being pain relief. More than 500 patients with painf
Publikováno v:
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 7(9)
This is a retrospective study of 15 postmenopausal or amenorrheic women aged 34–78 years who had taken prednisone for 6–108 months and were followed for 1 year while continuing to take doses of 5–15 mg/day. A total of 8 patients were treated wi
Publikováno v:
Seminars in nuclear medicine. 22(1)
Management of bone pain in patients with multiple osseous metastases is a significant clinical problem. Phosphorus-32 has been used as systemic radioisotope therapy for the management of bone pain for over 40 years. However, significant hematological
Publikováno v:
JAMA: The Journal of the American Medical Association. 274:420
Objective. —To present the current state of systemic radiopharmaceutical therapy for the palliation of pain in individuals with metastatic cancer and to evaluate the palliative effect and degree of hemotoxicity of strontium chloride 89 ( 89 Sr) in
Publikováno v:
Clinical Nuclear Medicine. 18:624